In addition, the DIP participant exhibits an insufficient initial insulin response, an extended period of hyperglycemia, and an excursion below the basal glucose level to a nadir glucose level of 58 mg/dl of glucose, all indicators of poor control of central metabolism. The gene discussed is INS; the disease is Hyperglycemia.